免疫性血小板减少症患儿外周血miR-320c、miR-4739和miR-3162-3p的表达及其临床意义
Expression and Clinical Significance of miR-320c, miR-4739 and miR-3162-3p in Peripheral Blood of Children with Immune Thrombocytopenia
DOI: 10.12677/ACM.2022.124536, PDF,   
作者: 闫 雪*:青岛大学医学院,山东 青岛;城市平邑县人民医院儿科,山东 临沂;李学荣#:青岛大学附属医院儿童血液肿瘤科,山东 青岛
关键词: 免疫性血小板减少症miR-320cmiR-4739miR-3162-3p诊断价值Immune Thrombocytopenia miR-320c miR-4739 miR-3162-3p Diagnostic Value
摘要: 目的:探讨免疫性血小板减少症(ITP)患儿血清miR-320c、miR-4739和miR-3162-3p的表达水平及其临床意义。方法:收集2019年8月~2021年8月青岛大学附属医院收治的96例ITP患儿作为ITP组,另在本院体检中心收集100例性别、年龄相匹配的健康儿童作为对照组。所有患儿行常规血小板检查,采用逆转录–聚合酶链式反应(RT-PCR)检测外周血miR-320c、miR-4739和miR-3162-3p表达水平。比较miR-320c、miR-4739和miR-3162-3p单独检测与联合检测对ITP的诊断价值。结果:与对照组比较,ITP组患儿PLT、PCT水平显著降低,MPV、PDW水平显著增加,差异具有统计学意义(P < 0.05)。RT-PCR结果显示,与对照组比较,ITP组患儿外周血miR-320c和miR-4739表达显著增加,miR-3162-3p表达显著降低,差异具有统计学意义(P < 0.05)。绘制ROC曲线结果显示,miR-320c单独检测诊断ITP的曲线下面积(AUC)为0.782,95%CI为0.733~0.831;miR-4739单独检测诊断ITP的AUC为0.774,95%CI为0.678~0.799;miR-3162-3p单独检测诊断ITP的AUC为0.739,95%CI为0.723~0.826;三者联合诊断的AUC为0.844,95%CI为0.813~0.875;联合诊断AUC大于单独诊断,差异具有统计学意义(P < 0.05)。结论:ITP患儿外周血血清miR-320c、miR-4739和miR-3162-3p表达异常,其表达水平可用于检测ITP,且三者联合检测,诊断价值更高,可作为早期诊断儿童ITP的生物标志物。
Abstract: Objective: To investigate the expression and clinical significance of miR-320c, miR-4739 and miR-3162-3p in serum of children with immune thrombocytopenia (ITP). Methods: A total of 96 ITP children admitted to the Affiliated Hospital of Qingdao University from August 2019 to August 2021 were selected as the ITP group. Another 100 healthy children with matched sex and age were collected as control group in the physical examination center of our hospital. All children underwent routine platelet examination. The expression levels of miR-320c, miR-4739 and miR-3162-3p in peripheral blood were detected by reverse transcription-polymerase chain reaction (RT-PCR). The diagnostic value of miR-320c, miR-4739 and miR-3162-3p individual and combined detection for ITP was compared. Results: Compared with the control group, the levels of PLT and PCT in ITP group were significantly decreased, while the levels of MPV and PDW were significantly increased, with statistical significance (P < 0.05). RT-PCR results showed that compared with the control group, the expressions of miR-320c and miR-4739 in the peripheral blood of children in the ITP group were significantly increased, and the expression of miR-3162-3p was significantly decreased, with statistical significance (P < 0.05). The ROC curve results showed that the area under the curve (AUC) of miR-320c alone for detecting and diagnosing ITP was 0.782, and 95%CI was 0.733~0.831. The AUC of miR-4739 alone in detecting and diagnosing ITP was 0.774 and 95%CI was 0.678~0.799. The AUC of miR-3162-3p alone was 0.739 and 95%CI was 0.723~0.826 for ITP detection. The AUC and 95%CI of combined diagnosis were 0.844 and 0.813~0.875 respectively. The AUC of combined diagnosis was greater than that of single diagnosis, and the difference was statistically significant (P < 0.05). Conclusions: The abnormal expressions of miR-320c, miR-4739 and miR-3162-3p in the peripheral blood serum of children with ITP can be used to detect ITP. Moreover, the combined detection of the three has higher diagnostic value and can be used as a biomarker for early diagnosis of ITP in children.
文章引用:闫雪, 李学荣. 免疫性血小板减少症患儿外周血miR-320c、miR-4739和miR-3162-3p的表达及其临床意义[J]. 临床医学进展, 2022, 12(4): 3717-3723. https://doi.org/10.12677/ACM.2022.124536

参考文献

[1] 于慧辉, 詹延霞, 季丽莉, 等. 原发性免疫性血小板减少症(ITP)患者CD5~+B细胞对CD4~+T细胞Th1/Th2型细胞因子分泌的影响[J]. 复旦学报(医学版), 2020(1): 53-58.
[2] Güngör, T., Arman Bilir, Ö., Koşan Çulha, V., et al. (2019) Retrospective Evaluation of Children with Immune Thrombocytopenic Purpura and Factors Contributing to Chronicity. Pediatrics & Neonatology, 60, 411-416. [Google Scholar] [CrossRef] [PubMed]
[3] 伍燕. 环孢素A联合丙种球蛋白治疗慢性免疫性血小板减少性紫癜临床效果[J]. 慢性病学杂志, 2020(9): 1397-1398+1401.
[4] Tumaini, M.J., Chen, Y. and Ke, Z. (2019) Efficacy and Safety of Thrombopoietin Receptor Agonists in Children with Chronic Immune Thrombocytopenic Purpura: Meta-Analysis. Platelets, 30, 828-835. [Google Scholar] [CrossRef] [PubMed]
[5] Stavast, C.J. and Erkeland, S.J. (2019) The Non-Canonical Aspects of MicroRNAs: Many Roads to Gene Regulation. Cells, 8, 1465. [Google Scholar] [CrossRef] [PubMed]
[6] Yu, K., Li, Q. and Li, N. (2018) MicroRNA Profile in Peripheral Blood Mononuclear Cells from Hepatitis B Virus Infected Patients. Annals of Hepatology, 17, 1012-1020. [Google Scholar] [CrossRef] [PubMed]
[7] El-Hefny, M., Fouad, S., Hussein, T., et al. (2019) Circulating microRNAs as Predictive Biomarkers for Liver Disease Progression of Chronic Hepatitis C (Genotype-4) Egyptian Patients. Journal of Medical Virology, 91, 93-101. [Google Scholar] [CrossRef] [PubMed]
[8] 林志, 高锡强, 霍桂桃, 等. 自身免疫性疾病中miRNAs对免疫耐受的调节作用[J]. 医学研究杂志, 2019, 48(9): 17-20.
[9] 孟燕婷, 孙博, 李呼伦. microRNAs在自身免疫性疾病中的研究进展[J]. 国际免疫学杂志, 2020, 43(5): 585-591.
[10] 刘咏萍, 李玉姝. miRNA-326在自身免疫性疾病中的研究进展[J]. 中国免疫学杂志, 2017, 33(2): 284-287.
[11] 周方伟, 许昱. miR-31免疫调节作用的机制研究进展[J]. 疑难病杂志, 2019, 18(12): 1293-1296.
[12] Zuo, B., Zhai, J., You, L., et al. (2017) Plasma microRNAs Characterising Patients with Immune Thrombocytopenic Purpura. Thrombosis and Haemostasis, 117, 1420-1431. [Google Scholar] [CrossRef
[13] Aripova, A., Akparova, A. and Bersimbaev, R. (2020) The Potential Role of miRNA-19b-3p and miRNA-320c in Patients with Moderate Bronchial Asthma. Microrna, 9, 373-377. [Google Scholar] [CrossRef] [PubMed]
[14] Dahiya, N. and Atreya, C.D. (2019) RAP1 Downregulation by miR-320c Reduces Platelet Activation in Ex-Vivo Storage. Microrna, 8, 36-42. [Google Scholar] [CrossRef] [PubMed]
[15] Li, J.Y., Cheng, B., Wang, X.F., et al. (2018) Circulating Microrna-4739 May Be a Potential Biomarker of Critical Limb Ischemia in Patients with Diabetes. BioMed Research International, 2018, Article ID: 4232794. [Google Scholar] [CrossRef] [PubMed]
[16] Wang, M., Xiong, L., Jiang, L.J., et al. (2019) miR-4739 Mediates Pleural Fibrosis by Targeting Bone Morphogenetic Protein 7. EBioMedicine, 41, 670-682. [Google Scholar] [CrossRef] [PubMed]
[17] Fang, C., Lu, W., Li, C., et al. (2016) MiR-3162-3p Is a Novel MicroRNA That Exacerbates Asthma by Regulating β-Catenin. PLoS ONE, 11, e0149257. [Google Scholar] [CrossRef] [PubMed]
[18] Liu, J., Chen, Y., Zhang, F., et al. (2020) Divergent Roles of miR-3162-3p in Pulmonary Inflammation in Normal and Asthmatic Mice as Well as Antagonism of miR-3162-3p in Asthma Treatment. International Archives of Allergy and Immunology, 181, 594-605. [Google Scholar] [CrossRef] [PubMed]
[19] Huang, J., Lai, J., Liang, B., et al. (2018) microRNA-3162-3p Is a Potential Biomarker to Identify New Infections in HIV-1-Infected Patients. Gene, 662, 21-27. [Google Scholar] [CrossRef] [PubMed]
[20] 张之南. 血液病诊断及疗效标准[M]. 第3版. 北京: 科学出版社, 2007: 172-176.
[21] 罗雅琴, 黄伟. 中药治疗免疫性血小板减少症的临床和实验研究进展[J]. 中国药物警戒, 2022, 19(4): 460-464.
[22] 陈丽娜, 宁建英. 免疫性血小板减少症(ITP)患儿血小板参数及骨髓象的临床意义[J]. 吉林医学, 2021, 42(4): 832-834.
[23] 王天有, 马洁, 方拥军, 等. 儿童原发性免疫性血小板减少症诊疗规范(2019年版) [J]. 全科医学临床与教育, 2019, 17(12): 1059-1062.
[24] 柳迎昭, 王胜军, 许化溪. microRNA与自身免疫疾病研究进展[J]. 安徽医学, 2014(7): 1016-1019.
[25] 李方林. miR-320c、msi-2在急性白血病患者中的表达及意义[D]: [硕士学位论文]. 南昌: 南昌大学, 2019.
[26] 王晨, 陈小岩, 陈新, 等. ALK阴性间变性大细胞淋巴瘤与CD30阳性非特殊型外周T细胞淋巴瘤的microRNA表达[J]. 中华病理学杂志, 2015, 44(8): 565-570.
[27] 陈玙, 王刚. miR-3162-3p靶向调节β-catenin在原发免疫性血小板减少症患者中临床意义研究[J]. 临床血液学杂志, 2020, 33(3): 341-343.